Shah N - Search Results

1

Characteristics and complications of anogenital infantile hemangiomas: A multicenter retrospective analysis.

Arnold JD, Yoon S, Shah N, Byrne M, Kieswetter L, Sibbald C, Lara-Corrales I, Kinariwalla N, Garzon MC, Braun M, Shah SD, Frieden IJ, Travis N, Liy Wong C, Snyder AN, Wine Lee L, Collier EK, Hogeling M, Fernandez Faith E, DeVaul N, Kirkorian AY. Arnold JD, et al. Among authors: shah n, shah sd. J Am Acad Dermatol. 2023 Nov;89(5):1015-1021. doi: 10.1016/j.jaad.2023.06.049. Epub 2023 Jul 13. J Am Acad Dermatol. 2023. PMID: 37451624

2

Relationship between sociodemographic factors and geographic distribution of pharmacies dispensing isotretinoin in Washington, DC.

Shah N, Truong M, Kirkorian AY. Shah N, et al. J Am Acad Dermatol. 2020 Sep;83(3):930-933. doi: 10.1016/j.jaad.2020.01.014. Epub 2020 Feb 13. J Am Acad Dermatol. 2020. PMID: 32063395 No abstract available.

3

Evaluating the barriers to isotretinoin treatment for acne vulgaris in pediatric patients.

Shah N, Smith E, Kirkorian AY. Shah N, et al. J Am Acad Dermatol. 2021 Dec;85(6):1597-1599. doi: 10.1016/j.jaad.2020.11.055. Epub 2020 Nov 28. J Am Acad Dermatol. 2021. PMID: 33259877 No abstract available.

4

Evaluating provider knowledge, perception, and concerns about cannabinoid use in pediatric dermatology.

Shah N, Kirkorian AY, Friedman AJ. Shah N, et al. Pediatr Dermatol. 2021 May;38(3):694-696. doi: 10.1111/pde.14539. Epub 2021 Mar 18. Pediatr Dermatol. 2021. PMID: 33738826

5

Clinical features and eosinophilia in pityriasis rubra pilaris: A multicenter cohort.

Ghatnekar S, Shah N, Min MS, Mazori DR, LaChance AH, Vleugels RA, Nambudiri VE. Ghatnekar S, et al. Among authors: shah n. J Am Acad Dermatol. 2022 Apr;86(4):907-909. doi: 10.1016/j.jaad.2021.03.043. Epub 2021 Mar 24. J Am Acad Dermatol. 2022. PMID: 33771592 No abstract available.

6

The administrative burden of prescribing and treating with isotretinoin.

Shah N, Smith E, Czermak J, Ferris M, Kirkorian AY. Shah N, et al. J Am Acad Dermatol. 2022 May;86(5):1165-1167. doi: 10.1016/j.jaad.2021.04.062. Epub 2021 Apr 24. J Am Acad Dermatol. 2022. PMID: 33905782 No abstract available.

7

The future of iPLEDGE: We pledge for more inclusive access to isotretinoin.

Shah N, Kirkorian AY. Shah N, et al. Pediatr Dermatol. 2021 Nov;38 Suppl 2:183-184. doi: 10.1111/pde.14673. Epub 2021 Jun 28. Pediatr Dermatol. 2021. PMID: 34184311 No abstract available.

8

Geographic variation of iPLEDGE-participating pharmacies across major metropolitan cities in the United States.

Shah N, Truong M, Antala S, Kirkorian AY. Shah N, et al. J Am Acad Dermatol. 2022 Jul;87(1):142-144. doi: 10.1016/j.jaad.2021.06.876. Epub 2021 Jul 6. J Am Acad Dermatol. 2022. PMID: 34242691 No abstract available.

9

Exploring the costs associated with isotretinoin treatment.

Shah N, Byrne M, Kirkorian AY. Shah N, et al. Pediatr Dermatol. 2021 Sep;38(5):1396-1399. doi: 10.1111/pde.14785. Epub 2021 Aug 31. Pediatr Dermatol. 2021. PMID: 34463375 Free PMC article.

10

The utility of laboratory testing for pediatric patients undergoing isotretinoin treatment.

Parthasarathy V, Shah N, Kirkorian AY. Parthasarathy V, et al. Among authors: shah n. Pediatr Dermatol. 2022 Sep;39(5):731-733. doi: 10.1111/pde.15045. Epub 2022 Jun 11. Pediatr Dermatol. 2022. PMID: 35689471

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

8,627 results

Search Page